search
Back to results

WalkMORE: A Volunteer-driven Walking Intervention (WalkMORE)

Primary Purpose

Frailty, Deconditioning, Early Ambulation

Status
Active
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
WalkMORE group
Sponsored by
Lawson Health Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Frailty

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Capable and appropriate for independent ambulation (with or without gait aids) as determined daily by the health care team
  2. Cognitively safe for participation
  3. Anticipated to remain hospitalized ≥48 hours
  4. Inpatient, admitted to Internal Medicine at University Hospital
  5. Age >18 years

Exclusion Criteria:

  1. Preexisting condition precludes patient from independent ambulation at time of admission
  2. Active medical condition precludes patient from safely participating
  3. Preexisting condition or active medical condition renders patient unfit to participate as judged by the admitting team
  4. Patients who refuse to participate or are unable to provide informed consent.
  5. Communication barrier (due to hearing/vision impairment, or language barrier)
  6. Patients receiving treatment from an LHSC inpatient Physiotherapist.

Sites / Locations

  • LHSC-University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Control

WalkMORE group

Arm Description

Patients receive no intervention

Patients will be randomized via REDCap (Research Electronic Data Capture), a secure, centralized web-based randomization module to: Standard of care; or WalkMORE Ambulation program + Standard of care. Patients will ambulate with a trained WalkMORE volunteer two times per day; once in the morning (0900-1200hrs) and once in the afternoon (1300-1700hrs), Monday- Friday, until hospital discharge. Patients randomized to the WalkMORE intervention will be assessed daily by the Research Coordinator to ensure patients remain fit for independent ambulation. The duration of each walking session will be determined daily by the RC and the medical team.

Outcomes

Primary Outcome Measures

Re-hospitalization
Number of patients re-admitted to hospital
Presentation to emergency department
Number of patients seen in the hospital emergency department
Prolonged index hospital admission
Number of patients with extended length of hospital admission

Secondary Outcome Measures

Length of stay for index hospital admission
Number of days patient was hospitalized
Post-discharge Falls
Composite of number of readmissions and emergency room visits secondary to patients experiencing a fall post-discharge
Timed-Up-And-Go
Measure of de-conditioning between the two study arms using
Barthel Index
ordinal scale used to measure performance in activities of daily living. Minimum score is zero and maximum score is 100, higher score represent better outcomes.
Frailty
Measure of frailty between the two study arms using the Jamar Hand Dynamometer data
Deconditioning
total steps as measured by pedometer as a measure of deconditioning
Increased number of steps
proportion of patients who increase step count by 200 steps per day
EQ-5D
A STANDARDIZED INSTRUMENT FOR USE AS A MEASURE OF HEALTH OUTCOME. The EQ-VAS scale ranges from a minimum of zero and a maximum of 100 and is the participants subjective score of how good or poor their health is at the time the scale is presented to them. Higher values represent a better outcome

Full Information

First Posted
March 13, 2019
Last Updated
March 16, 2023
Sponsor
Lawson Health Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT03888027
Brief Title
WalkMORE: A Volunteer-driven Walking Intervention
Acronym
WalkMORE
Official Title
A Randomized Controlled Trial of a Volunteer-driven Walking Intervention to Improve Hospital-associated Deconditioning and Frailty
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 6, 2019 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Lawson Health Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Patients admitted to hospital typically experience periods of decreased activity or bed-rest. This reduced activity level leads to deconditioning - a loss of muscle mass, muscle strength (by 2-5% per day), and muscle shortening. Even among patients who were ambulatory at the time of admission, deconditioning has been linked with deleterious effects, such as increased rates of falls, functional decline, and frailty. Furthermore, it has been suggested that the physiological stresses associated with hospitalization - including deconditioning, as well as sleep deprivation and poor nutrition - makes discharged patients vulnerable to recurrent or new illnesses and to frailty. This physiological stress-induced vulnerability has been coined "post-hospital syndrome" and is thought to have a role in most hospital readmissions. The investigators hypothesize that by engaging ambulatory patients to walk with trained volunteers, patients will increase their amount of walking, have less deconditioning and functional decline, and consequently, fewer falls. Furthermore, the investigators anticipate that patients who walk with a trained volunteer will have reduced length-of-stay in hospital and decreased likelihood of readmission. Finally, as shown in other similar programs, the investigators anticipate an overall improvement in the patient experience. The investigator's novel initiative focuses on a single, volunteer-based intentional ambulation program that can deliver the benefits of early mobility in a cost-effective way. The program design engages trained volunteers to increase patient ambulation in a way that both increases patient mobility and reduces healthcare professionals' workload.
Detailed Description
WalkMORE is a single-center randomized controlled trial. The investigators will enroll up to 800 ambulatory patients admitted to the Internal Medicine unit (located on the 4th floor of University Hospital) who are >18 years of age and are anticipated to require a >48 hour hospital admission. A maximum of 6 patients will be assigned to each treatment arm at any given time. The investigators will recruit patients into the WalkMORE program over a 2 year period. The research coordinator (RC) will screen patients admitted to the Internal Medicine unit in the preceding 24-hour period to identify patients who fulfill the eligibility criteria. Patients will be randomized via REDCap (Research Electronic Data Capture), a secure, centralized web-based randomization module to: Standard of care; or WalkMORE Ambulation program + Standard of care. Patients will ambulate with a trained WalkMORE Volunteer two times per day; once in the morning (0900-1200 hrs) and once in the afternoon (1300-1600 hrs), Monday- Friday, until hospital discharge. Patients randomized to the WalkMORE intervention will be assessed daily by the RC to ensure patients remain fit for independent ambulation. The duration of each walking session will be determined daily by the RC and the medical team. After obtaining written informed consent from eligible patients the RC will randomize patients, collect demographics and hospital admission details from patients' hospital charts and perform the Barthel Index and complete the Charlson Comorbidity Index (CCI) for all patients. The Barthel Index (BI) measures the extent to which patients can function independently and has mobility in their activities of daily living (ADL). The Charlson Comorbidity Index categorizes and scores the comorbidities of patients. The CCI can be used to predict short term and long-term outcomes such as function, hospital length of stay and mortality rates. The CCI will be completed using information gathered from patients' hospital chart.with all patients. All patients will be assigned a scientific pedometer on the day of randomization. The modus Health StepWatch™ is an activity monitor worn on the ankle via a velcro strap. It is a small, lightweight device that will count and record patients' steps throughout hospital stay, ending at hospital discharge. Research personnel will be responsible for fitting the StepWatch monitor to patients' ankle. The device is smaller than a deck of cards (7.5 x 5.0 x 2.0 cm) and weighs 38 grams. Frailty and de-conditioning will be measured on Study Day 3. Frailty will be assessed using the Jamar Hand Dynamometer. Patients are instructed to squeeze the handle of the instrument with their maximum force for three seconds; the peak-hold (in kilograms) is recorded on the instrument. Three successive peak-hold measurements will be recorded. The device measures 10 x 20 x 33cm and weighs 1.3 kg. Deconditioning will be measured using the Timed Up and Go (TUG) test, patients will be asked to stand up from a chair, walk three metres, turn around, and walk back to the chair and sit. After hospital discharge the RC will follow up with patients for 2 brief telephone interviews. On the third day after discharge, Patient Satisfaction surveys will be conducted by the RC to assess patient satisfaction with their hospital experience and with the WalkMORE program. On day 30 after randomization, the RC will contact patients to conduct a brief interview consisting of: a health status survey (EQ-5D), a functional status assessment (Barthel Index) and to collect data regarding clinical outcomes (ER visits, re-hospitalizations, and falls). Each telephone interview is expected to last approximately 10 minutes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Frailty, Deconditioning, Early Ambulation

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Patients will be randomized via REDCap (Research Electronic Data Capture), a secure, centralized web-based randomization module to: Standard of care; or WalkMORE Ambulation program + Standard of care. Patients will ambulate with a trained WalkMORE Volunteer Coach two times per day; once in the morning (0900-1200hrs) and once in the afternoon (1300-1700hrs), Monday- Friday, until hospital discharge. Patients randomized to the WalkMORE intervention will be assessed daily by the Research Coordinator to ensure patients remain fit for independent ambulation. The duration of each walking session will be determined daily by the RC and the medical team.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
800 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
Patients receive no intervention
Arm Title
WalkMORE group
Arm Type
Active Comparator
Arm Description
Patients will be randomized via REDCap (Research Electronic Data Capture), a secure, centralized web-based randomization module to: Standard of care; or WalkMORE Ambulation program + Standard of care. Patients will ambulate with a trained WalkMORE volunteer two times per day; once in the morning (0900-1200hrs) and once in the afternoon (1300-1700hrs), Monday- Friday, until hospital discharge. Patients randomized to the WalkMORE intervention will be assessed daily by the Research Coordinator to ensure patients remain fit for independent ambulation. The duration of each walking session will be determined daily by the RC and the medical team.
Intervention Type
Behavioral
Intervention Name(s)
WalkMORE group
Intervention Description
Hospitalized Internal Medicine patients will walk with trained volunteers twice daily until hospital discharge.
Primary Outcome Measure Information:
Title
Re-hospitalization
Description
Number of patients re-admitted to hospital
Time Frame
30 days after randomization
Title
Presentation to emergency department
Description
Number of patients seen in the hospital emergency department
Time Frame
30 days after randomization
Title
Prolonged index hospital admission
Description
Number of patients with extended length of hospital admission
Time Frame
30 days after randomization
Secondary Outcome Measure Information:
Title
Length of stay for index hospital admission
Description
Number of days patient was hospitalized
Time Frame
30 days after randomization
Title
Post-discharge Falls
Description
Composite of number of readmissions and emergency room visits secondary to patients experiencing a fall post-discharge
Time Frame
30 days after randomization
Title
Timed-Up-And-Go
Description
Measure of de-conditioning between the two study arms using
Time Frame
30 days after randomization
Title
Barthel Index
Description
ordinal scale used to measure performance in activities of daily living. Minimum score is zero and maximum score is 100, higher score represent better outcomes.
Time Frame
30 days after randomization
Title
Frailty
Description
Measure of frailty between the two study arms using the Jamar Hand Dynamometer data
Time Frame
30 days after randomization
Title
Deconditioning
Description
total steps as measured by pedometer as a measure of deconditioning
Time Frame
30 days after randomization
Title
Increased number of steps
Description
proportion of patients who increase step count by 200 steps per day
Time Frame
30 days after randomization
Title
EQ-5D
Description
A STANDARDIZED INSTRUMENT FOR USE AS A MEASURE OF HEALTH OUTCOME. The EQ-VAS scale ranges from a minimum of zero and a maximum of 100 and is the participants subjective score of how good or poor their health is at the time the scale is presented to them. Higher values represent a better outcome
Time Frame
30 days after randomization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Capable and appropriate for independent ambulation (with or without gait aids) as determined daily by the health care team Cognitively safe for participation Anticipated to remain hospitalized ≥48 hours Inpatient, admitted to Internal Medicine at University Hospital Age >18 years Exclusion Criteria: Preexisting condition precludes patient from independent ambulation at time of admission Active medical condition precludes patient from safely participating Preexisting condition or active medical condition renders patient unfit to participate as judged by the admitting team Patients who refuse to participate or are unable to provide informed consent. Communication barrier (due to hearing/vision impairment, or language barrier) Patients receiving treatment from an LHSC inpatient Physiotherapist.
Facility Information:
Facility Name
LHSC-University Hospital
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5A5
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

WalkMORE: A Volunteer-driven Walking Intervention

We'll reach out to this number within 24 hrs